FMCG Gurus -FMCG Gurus – Weight Loss Medication Usage, Trends, Challenges & What’s Next – Global Report – 2025

FMCG Gurus – Weight Loss Medication Usage, Trends, Challenges & What’s Next – Global Report – 2025

  • EUR (€)
  • GBP (£)
  • USD ($)

FMCG Gurus – Weight Loss Medication Usage, Trends, Challenges & What’s Next – Global Report – 2025

 Geographies: Global  Industries: Healthy Ageing, Weight Loss Medication  Published Date: 2025

Buy Now for £2400

FMCG Gurus – Weight Loss Medication Usage, Trends, Challenges & What’s Next – Global Report – 2025

Report Description:

Over the past year, FMCG Gurus has explored the emerging impact of GLP-1 weight loss medication on consumer behavior towards food and drink. As interest in GLP-1 medication intensifies, especially among consumers seeking faster solutions to manage their weight, brands must understand how this trend could disrupt traditional dietary behaviors.

Looking at global consumers and the four age cohorts, this report examines perceptions, usage and challenges around weight loss medication, including where consumers see this market in five years time. It also explores the lifestyle of consumers that take this medication, where they are seeking information about weight loss and advice given by healthcare professionals. The report also looks at interest in food and drink that naturally stimulates GLP-1 hormones.

This report will look at the following areas:

  • Awareness and perceptions of GLP-1 medication, including perceived efficacy and risks.
  • Overall usage of GLP-1 medication and amongst the four age cohorts.
  • Proportion of consumers that previously used weight loss medication and side effects that these consumers experienced after stopping the medication.
  • The lifestyle of consumers that use GLP-1 medication and whether they have already tried to lose weight.
  • The length of time that users have been taking GLP-1 medication and whether they have seen noticeable results.
  • The reasons why consumers are using GLP-1 medication and the additional steps that people have taken to improve their overall health and lifestyle.
  • Side effects that consumers have experienced while using weight loss medication and how this has affected usage.
  • How effective consumers feel that this medication has been in the long-term.
  • The challenges and concerns that consumers have identified for the weight loss medication market.
  • The type of regulation that consumers would like to see around weight loss medication.
  • Consumer interest in food and drink that stimulates GLP-1 medication.
  • Actions and recommendations for targeting the weight loss medication market.

FMCG Gurus – Weight Loss Medication Usage, Trends, Challenges & What’s Next – Global Report – 2025

Report Description:

Over the past year, FMCG Gurus has explored the emerging impact of GLP-1 weight loss medication on consumer behavior towards food and drink. As interest in GLP-1 medication intensifies, especially among consumers seeking faster solutions to manage their weight, brands must understand how this trend could disrupt traditional dietary behaviors.

Looking at global consumers and the four age cohorts, this report examines perceptions, usage and challenges around weight loss medication, including where consumers see this market in five years time. It also explores the lifestyle of consumers that take this medication, where they are seeking information about weight loss and advice given by healthcare professionals. The report also looks at interest in food and drink that naturally stimulates GLP-1 hormones.

This report will look at the following areas:

  • Awareness and perceptions of GLP-1 medication, including perceived efficacy and risks.
  • Overall usage of GLP-1 medication and amongst the four age cohorts.
  • Proportion of consumers that previously used weight loss medication and side effects that these consumers experienced after stopping the medication.
  • The lifestyle of consumers that use GLP-1 medication and whether they have already tried to lose weight.
  • The length of time that users have been taking GLP-1 medication and whether they have seen noticeable results.
  • The reasons why consumers are using GLP-1 medication and the additional steps that people have taken to improve their overall health and lifestyle.
  • Side effects that consumers have experienced while using weight loss medication and how this has affected usage.
  • How effective consumers feel that this medication has been in the long-term.
  • The challenges and concerns that consumers have identified for the weight loss medication market.
  • The type of regulation that consumers would like to see around weight loss medication.
  • Consumer interest in food and drink that stimulates GLP-1 medication.
  • Actions and recommendations for targeting the weight loss medication market.

How This Report Can Benefit the Industry:

  • Identify opportunities to innovate and reposition products in a shifting weight-management market.
  • Understand the emerging risks and reputational challenges tied to the medicalization of weight loss.
  • Anticipate how consumer behavior will change and how best to adapt to accomodate for these changes.

Files included in this report:

  • FMCG-Gurus-Weight-Loss-Medication-Usage-Trends-Challenges-What’s-Next-Global-Report-2025.pdf
  • FMCG-Gurus-Weight-Loss-Medication-Usage-Trends-Challenges-What’s-Next-Global-Report-2025.pptx
  • If you are a user, click here to login and download the report.

Report Agenda and Insights available:

Section 2: Usage & Results
  • [WLM400] How do you think the weight loss drugs/ injection market will evolve over the next five years? Please select the answer that best fits - 2025
  • [WLM121] Do you think that GLP-1 drugs or injections such as Ozempic or Wegovy will reverse obesity rates in your country in the long-term? - 2025
  • [WLM241] Had you tried to lose weight in other ways (such as through dieting and more exercise) before you started using GLP-1 drugs or injections such as Ozempic or Wegovy? Please select the answer that best fits - 2025
  • [WLM075] To what extent do you agree with the following statements? Please select the answer that best fits - 2025
  • [WLM377] How long have you been using weight loss drugs/injections for? - 2025
  • [WLM985] To what extent do you agree with the following statements? Please select all that apply - 2025
  • [WLM981] Did the healthcare professional discuss how long you would be using GLP-1 drugs or injections such as Ozempic or Wegovy? - 2025
  • [WLM586] Did the healthcare professional discuss how long you would be using GLP-1 drugs or injections such as Ozempic or Wegovy? Please select the answer that best fits - 2025
  • [WLM860] Do you use GLP-1 drugs or injections such as Ozempic or Wegovy for any additional reason beyond weight loss? Please select all that apply - 2025
  • [WLM598] Have you taken any additional steps to improve your overall diet and lifestyle? - 2025
  • [WLM104] What side effects have you experienced? Please select all that apply - 2025
  • [WLM979] Have you experienced any side-effects when using GLP-1 drugs or injections such as Ozempic or Wegovy? - 2025
  • [WLM159] Have the side-effects been severe enough for you to consider no longer using GLP-1 drugs or injections such as Ozempic or Wegovy? Please select the answer that best fits - 2025
Section 4: Actions & Recommendations
  • [WLM681] Would you be interested to buy a food or beverage that stimulates your GLP-1 hormones in a natural way? - 2025
  • [WLM681] Would you be interested to buy a food or beverage that stimulates your GLP-1 hormones in a natural way? - 2025

Files included in this report:

  • FMCG-Gurus-Weight-Loss-Medication-Usage-Trends-Challenges-What’s-Next-Global-Report-2025.pdf
  • FMCG-Gurus-Weight-Loss-Medication-Usage-Trends-Challenges-What’s-Next-Global-Report-2025.pptx
  • If you are a user, click here to login and download the report.